Upstream key raw materials of biological drugs: Tofflon independent homegrown culture medium Opening Message

Opening Message

       In 2023, Tofflon Bio-reagent opens a new chapter of rapid development, and continues to deepen the research and development, transformation and commercial production and supply of homegrown culture medium, to create a comprehensive reagent platform integrating research and development, innovation, application and transformation, production and sales of key reagents.With the guidance of standardization, standardization and internationalization, Tofflon casts China's independent international leading reagent brand, and endeavors to realize the independent research and development and mass production of key biological reagents by practicing the localization of medium replacement.

Tofflon independent localization of medium development

       In order to further improve the overall solution of Tofflon biological medicine systematization, in 2021, Tofflon Group established Shanghai Tofflon Bio-reagent under the life science section, focusing on the R&D, transformation and large-scale production of the whole culture medium and key reagent products.Key reagents of medium are combined with Tofflon systematic engineering, core equipment and disposable consumables to form a closed loop of overall solution for the research and development and industrialization of life science and biological industry, and to serve biological drugs with professional technology.

Based on laws and regulations, it provides safe and stable conformance products

       Product development and production based on the regulatory compliance, in strict accordance with the requirements of biological drugs raw materials and auxiliary materials to provide animal-free, serum-free products, committed to complete chemical composition limited medium development and transformation.The production of medium adopts the world's most advanced needle grinding technology and one-time liquid dispensing filling process, strictly referring to cGMP and ISO13485 requirements for production.

Focus on the pain points of biological drug development and production, and escort the application of biological drug product development and marketing

       We provide process application and development support based on application scenarios. According to different applications and types of biological drug R&D and production, we provide overall connection programs and application support for key reagents:

■We provide industrialization and large-scale production process route support, based on medium application technology, combined with Tofflon cell preparation station, SUB, separation and purification and other core equipment, to support the scale and industrialization of biological drug projects.

■We have perfect system documents and registration qualifications: starting from drug application and commercial listing, supporting products to provide complete product documents and registration records, to provide product compliance documents and declaration support.

Tofflon Bio-reagents adhering to the mission of Tofflon people, with professional technology to serve the biomedicine.